Use of the 13C-sucrose breath test to assess chemotherapy-induced small intestinal mucositis in the rat

Cancer Biology and Therapy

Volumn 5, Issue 1, 2006, Pages 34-38

  Clarke, Julie M ^a,b   Pelton, Nicole C ^a   Bajka, Balazs H ^a   Howarth, Gordon S ^a,b,c   Read, Leanna C ^a,b   Butler, Ross N ^a,b,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Breath test; Folinate; Methotrexate; Mucositis; Rat; Sucrase

Indexed keywords

CARBON 13; FOLINATE CALCIUM; FOLINIC ACID; METHOTREXATE; SUCRASE; SUCROSE; ANTINEOPLASTIC ANTIMETABOLITE; CARBON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATH ANALYSIS; CANCER PATIENT; CELL PROTECTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL TOXICITY; INTESTINE FUNCTION; INTESTINE INJURY; MUCOSA INFLAMMATION; NON INVASIVE MEASUREMENT; NONHUMAN; RAT; SCREENING TEST; SMALL INTESTINE MUCOSA; SUCROSE HYDROGEN BREATH TEST; ANIMAL; CHEMICALLY INDUCED DISORDER; EVALUATION; METHODOLOGY; PATHOLOGY; SMALL INTESTINE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BREATH TESTS; CARBON ISOTOPES; INTESTINE, SMALL; METHOTREXATE; MUCOSITIS; RATS; SUCROSE;

EID: 32544460860     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.1.2235     Document Type: Article

References (34)

1. Pico JL, Avila-Garavito A, Naccache P. Mucositis: Its occurrence, consequences, and treatment in the oncology setting. Oncologist 1998; 3:446-51.
2. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999; 85:2103-13.
3. Diddens H, Teufel T, Niethammer D. High-dose methotrexate therapy with leucovorin rescue - Invitro investigations on human osteosarcoma cell-lines. Cancer Chemotherapy and Pharmacology 1987; 20:128-32.
4. Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci (Lond) 1997; 92:385-9.
5. Gray GM. Carbohydrate digestion and absorption. Role of the small intestine. N Engl J Med 1975; 292:1225-30.
6. Asp NG, Gudmand-Hoyer E, Andersen B, Berg NO, Dahlqvist A. Distribution of disaccharidases, alkaline phosphatase, and some intracellular enzymes along the human small intestine. Scand J Gastroenterol 1975; 10:647-51.
7. Xian CJ, Couper R, Howarth GS, Read LC, Kallincos NC. Increased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositis. British Journal of Cancer 2000; 82:945-52.
8. Pelton NS, Tivey DR, Howarth GS, Davidson GP, Butler RN. A novel breath test for the noninvasive assessment of small intestinal mucosal injury following methotrexate administration in the rat. Scandinavian Journal of Gastroenterology 2004; 39:1015-6.
9. Gibson RJ, Keefe DMK, Thompson FM, Clarke JM, Goland GJ, Cummins AG. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Digestive Diseases and Sciences 2002; 47:2751-7.
10. Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP. Mechanisms of action of methotrexate. Immunopharmacology 2000; 47:247-57.
11. A lange clinical manual: Practical oncology. Appleton and Lange 1994.
12. Tomas FM, Murray AJ, Jones LM. Interactive effects of insulin and corticosterone on myofibrillar protein turnover in rats as determined by N tau-methylhistidine excretion. Biochem J 1984; 220:469-79.
13. Howarth GS, Francis GL, Cool JC, Xu X, Byard RW, Read LC. Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J Nutr 1996; 126:2519-30.
14. Morris TH. Antibiotic therapeutics in laboratory animals. Lab Anim 1995; 29:16-36.
15. Symonds EL, Butler RN, Omari TI. Assessment of gastric emptying in the mouse using the [C-13]-octanoic acid breath test. Clinical and Experimental Pharmacology and Physiology 2000; 27:671-5-
16. Di Stefano M, Miceli E, Malservisi S, Missanelli A, Strocchi A, Corazza GR. Mixing of the intestinal content and variations of fermentation capacity do not affect the results of hydrogen breath test. Am J Gastroenterol 2003; 98:1584-7.
17. Dahlqvist A. Assay of intestinal disaccharidases. Anal Biochem 1968; 22:99-107.
18. Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989; 96:29-36.
19. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78:206-9.
20. Ijiri K, Potten CS. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer 1983; 47:175-85.
21. Duncan M, Grant G. Review article: Oral and intestinal mucositis - causes and possible treatments. Alimentary Pharmacol Therapeutics 2003; 18:853-74.
22. Oberbaum M, Yaniv I, Ben Gal Y, et al. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer 2001; 92:684-90.
23. Meropol NJ, Somer RA, Gutheil J, et al. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: Potential role as mucosal protectant. Journal of Clinical Oncology 2003; 21:1452-8.
24. Anderson PM, Schroeder G, Skubitz KM. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 1998; 83:1433-9.
25. Sonis ST. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncology 1998; 34:39-43.
26. Piccirillo N, De Matteis S, Laurenti L, et al. Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: Effects on immune reconstitution and mucositis. Haematologica 2003; 88:192-200.
27. Keefe DMK, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47:632-7.
28. Howarth GS, Cool JC, Bourne AJ, Ballard FJ, Read LC. Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate. Growth Factors 1998; 15:279-92.
29. Kanauchi O, Mitsuyama K, Saiki T, Agata K, Nakamura T, Iwanaga T. Preventive effects of germinated barley foodstuff on methotrexate-induced enteritis in rats. Int J Mol Med 1998; 1:961-6.
30. Warden RA, Noltorp RS, Francis JL, Dunkley PR, O'Loughlin EV. Vitamin A deficiency exacerbates methotrexate-induced jejunal injury in rats. J Nutr 1997; 127:770-6.
31. Nieminen U, Kahri A, Savilahti E, Farkkila MA. Duodenal disaccharidase activities in the follow-up of villous atrophy in coeliac disease. Scand J Gastroenterol 2001; 36:507-10.
32. Kralovanszky J, Prajda N. Biochemical changes of intestinal epithelial cells induced by cytostatic agents in rats. Arch Toxicol Suppl 1985; 8:94-103.
33. Davidson GP, Gall DG, Petric M, Butler DG, Hamilton JR. Human rotavirus enteritis induced in conventional piglets. Intestinal structure and transport. J Clin Invest 1977; 60:1402-9.
34. Jourdan N, Brunet JP, Sapin C, et al. Rotavirus infection reduces sucrase-isomaltase expression in human intestinal epithelial cells by perturbing protein targeting and organization of microvillar cytoskeleton. J Virol 1998; 72:7228-36.